Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HiperScan is a German medical technology company specializing in high-performance near-infrared (NIR) spectroscopy solutions. The company's flagship product, Apo-Ident, is a widely used system in pharmacies for the rapid and non-destructive identification of starting materials and chemicals in accordance with pharmacopoeia requirements. Utilizing proprietary Micro-Electro-Mechanical Systems (MEMS) technology developed at the Fraunhofer Institute, HiperScan provides analytical instruments that streamline quality control processes in the pharmaceutical and food industries. Their solutions enable users to perform precise substance analysis without extensive laboratory training, ensuring safety and regulatory compliance. HiperScan is recognized as a leader in miniaturized NIR spectroscopy, offering both hardware and comprehensive spectral databases for substance identification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HiperScan.